Clinical Trials Logo

Clinical Trial Summary

The study will be a multicenter, randomized, double-blind, follow-up clinical trial. Neither the examining doctor nor the patient knows which capsule they will receive. Just the test unlock the codes after completion. T


Clinical Trial Description

The study will be a multicenter, randomized, double-blind, follow-up clinical trial. Neither the examining doctor nor the patient knows which capsule they will receive. Just the test unlock the codes after completion. The randomization was performed externally, not included in the study performed by a person. Number of patients: a total of 105 patients / 25-25 per clinic (with 8 patients each in three treatment groups) Three treatment groups - 35 people physical therapy + Loxacon - 35 main physical therapy + Placebo - 35 people only for physical therapy Physiotherapy(exercise) takes place according to a uniform protocol. Physiotherapy 2x30 minutes per week for 5 weeks (10 times in total). The course of the investigation 1. st visit: selection, filling in questionnaires 2. nd visit: after the 10th exercise session, while taking Loxacon/placebo, filling in questionnaires 3. rd visit: Uniformly after another 2 months of taking Loxacon, in all three groups, completing questionnaires After the first 5 weeks, all three branches will receive enough Loxacon capsules for 2 months! The parameters to be tested - WOMAC test - VAS - EQ-5D-5L quality of life test - Goniometer angle measurement The test is completed by patients who participated in more than 70% of the treatment! Monitoring of side effects It is the duty of the doctor of the given center - who reports to the investigator. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05925725
Study type Interventional
Source Polyclinic of the Hospitaller Brothers of St. John of God, Budapest
Contact
Status Completed
Phase Phase 4
Start date January 25, 2023
Completion date September 6, 2023

See also
  Status Clinical Trial Phase
Terminated NCT04040985 - Legion Primary Safety and Efficacy N/A
Active, not recruiting NCT04525950 - Robotized Navigation Compared to Conventional Technique in Total Knee Replacement N/A
Recruiting NCT04320914 - High Intensity Laser Therapy (Classes IV) and Ibuprofen Gel Phonophoresis for Treating Knee Osteoarthritis N/A
Completed NCT03886142 - Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis N/A
Terminated NCT04072055 - MOTO Post-marketing Surveillance Study
Not yet recruiting NCT06385275 - The Role of Vitamin K on Knee Osteoarthritis Outcomes Phase 1/Phase 2
Not yet recruiting NCT05290818 - Total Versus Robotic Assisted Unicompartmental Knee Replacement N/A
Withdrawn NCT03271229 - Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee Phase 2
Recruiting NCT05505552 - Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis: N/A
Recruiting NCT05992038 - Use of a Putty as Gap Filler in Open-wedge Osteotomy N/A
Recruiting NCT06066684 - Pain Phenotyping in Knee OA: a Pilot Trial
Completed NCT03847324 - Physiotherapy and Therapeutic Education on Patients With Pain Catastrophism Scheduled for a Total Knee Arthroplasty N/A
Recruiting NCT05126485 - Biofeedback Retention in Individuals With AKA Early Phase 1
Completed NCT04956393 - The SOAR (Stop OsteoARthritis) Program Proof-of-Concept Study N/A
Recruiting NCT04541342 - Arthroscopic Evaluation of Cartilage Regeneration After Opening-wedge High Tibial Osteotomy N/A
Completed NCT04391842 - Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis Phase 1
Completed NCT03680807 - Power Production in Older Adults With Knee Osteoarthritis
Completed NCT03783455 - Effectiveness of Five Intraarticular Strategies on Knee Osteoarthritis N/A
Not yet recruiting NCT06264362 - Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia N/A
Completed NCT05089253 - Effect of Physical Therapy Modalities in Osteoarthritis N/A